Barclays is reiterating an Overweight rating on Xilinx (XLNX +1.5%) following FQ1 results; it...

|By:, SA News Editor

Barclays is reiterating an Overweight rating on Xilinx (XLNX +1.5%) following FQ1 results; it expects Xilinx's market share losses - revenue growth has been far behind archrival Altera's (ALTR) - slowing as newer FPGA chip products ramp, and as Xilinx gets a head start on Altera in producing chips using 28nm manufacturing technology. (PR) (transcript)